Elicio Therapeutics (ELTX) Other Working Capital Changes (2020 - 2025)
Elicio Therapeutics (ELTX) reported Other Working Capital Changes of $142000.0 for Q4 2025, up 167.94% on a YoY basis from $52996.4 in Q4 2024, and up 12.7% quarter-over-quarter from $126000.0 in Q3 2025.
Elicio Therapeutics (ELTX) Other Working Capital Changes (2020 - 2025) Analysis & Trends
Elicio Therapeutics has reported Other Working Capital Changes for 6 years, with the latest figure at $142000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes rose 167.94% year-over-year to $142000.0; the trailing twelve-month figure through Mar 2026 stood at -$905000.0 (down 608.43% YoY), and the FY2025 full-year result was -$901000.0, up 1.1% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at $142000.0, up from $126000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $1.7 million in Q3 2022, with the low at -$2.0 million in Q4 2022.
- Historically, Other Working Capital Changes has averaged -$215833.3 across 5 years, with a median of -$223000.0 in 2023.
- The largest YoY upside for Other Working Capital Changes was 443.28% in 2022 against a maximum downside of 889.37% in 2022.
- Elicio Therapeutics' Other Working Capital Changes stood at -$207000.0 in 2021, then tumbled by 889.37% to -$2.0 million in 2022, then soared by 88.43% to -$237000.0 in 2023, then rose by 11.81% to -$209000.0 in 2024, then surged by 167.94% to $142000.0 in 2025.
- The last three Other Working Capital Changes figures came in at $142000.0 (Q4 2025), $126000.0 (Q3 2025), and -$1.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Elicio Therapeutics | 70.12 Mn | 55.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 142,000.00 |
| Dec 31, 2025 | 142,000.00 |
| Sep 30, 2025 | 126,000.00 |
| Sep 30, 2025 | 126,000.00 |
| Jun 30, 2025 | -1.17 Mn |
| Jun 30, 2025 | -1.17 Mn |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | -209,000.00 |
| Dec 31, 2024 | -209,000.00 |
| Sep 30, 2024 | -358,000.00 |
| Sep 30, 2024 | -358,000.00 |
| Jun 30, 2024 | 741,000.00 |
| Jun 30, 2024 | 741,000.00 |
| Mar 31, 2024 | -1.09 Mn |
| Mar 31, 2024 | -1.09 Mn |
| Dec 31, 2023 | -237,000.00 |
| Dec 31, 2023 | -237,000.00 |
| Sep 30, 2023 | -251,000.00 |
| Sep 30, 2023 | -251,000.00 |